BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8797750)

  • 1. Prevention of variceal rebleeding.
    Stevermer JJ; Chambliss ML
    J Fam Pract; 1996 Sep; 43(3):240-1. PubMed ID: 8797750
    [No Abstract]   [Full Text] [Related]  

  • 2. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding.
    Villanueva C; Balanzó J; Novella MT; Soriano G; Sáinz S; Torras X; Cussó X; Guarner C; Vilardell F
    N Engl J Med; 1996 Jun; 334(25):1624-9. PubMed ID: 8628357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy for secondary prophylaxis of variceal rebleeding?
    Maldonado D; Barkin JS
    Am J Gastroenterol; 2002 Aug; 97(8):2134-6. PubMed ID: 12190191
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Lin CK; Tsai WL; Chan HH; Chen TA; Yu HC; Hsu PI; Lai KH
    Hepatology; 2008 Aug; 48(2):580-7. PubMed ID: 18666235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
    Bosch J
    P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial.
    Romero G; Kravetz D; Argonz J; Vulcano C; Suarez A; Fassio E; Dominguez N; Bosco A; Muñoz A; Salgado P; Terg R
    Aliment Pharmacol Ther; 2006 Aug; 24(4):601-11. PubMed ID: 16827811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal bleeding: Secondary prophylaxis for variceal bleeding.
    Kravetz D
    Nat Rev Gastroenterol Hepatol; 2010 Jan; 7(1):10-1. PubMed ID: 20051968
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of cirrhosis and ascites.
    Bhaskar ME
    N Engl J Med; 2004 Jul; 351(3):300-1; author reply 300-1. PubMed ID: 15257569
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of varices rebleeding: are drugs better after all?
    Blendis L; Wong F
    Gastroenterology; 2002 Mar; 122(3):832-3. PubMed ID: 11875021
    [No Abstract]   [Full Text] [Related]  

  • 12. Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Chen MH; Hsu PI; Lin CK; Tsai WL; Lai KH
    Gastroenterology; 2002 Sep; 123(3):728-34. PubMed ID: 12198699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical decompressive therapy for prophylaxis of rebleeding.
    Lebrec D
    Digestion; 1998 Jul; 59 Suppl 2():48-9. PubMed ID: 9718420
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis.
    Gonzalez-Suarez B; Guarner C; Villanueva C; Minana J; Soriano G; Gallego A; Sainz S; Torras X; Cusso X; Balanzo J
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):49-55. PubMed ID: 16357619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials.
    Bai M; Qi X; Yang M; Han G; Fan D
    J Gastroenterol Hepatol; 2014 Mar; 29(3):442-52. PubMed ID: 24118091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial.
    García-Pagán JC; Villanueva C; Albillos A; Bañares R; Morillas R; Abraldes JG; Bosch J;
    Gut; 2009 Aug; 58(8):1144-50. PubMed ID: 19218249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis of variceal bleeding.
    Thuluvath PJ; Krishnan A
    Gastrointest Endosc; 2003 Oct; 58(4):558-67. PubMed ID: 14520290
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding.
    Lo GH; Chen WC; Chan HH; Tsai WL; Hsu PI; Lin CK; Chen TA; Lai KH
    J Gastroenterol Hepatol; 2009 Jun; 24(6):982-7. PubMed ID: 19638080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.